Time | Session |
---|---|
1:00 pm – 1:05 pm | Welcome, roll call
Kara Elam, PhD, MPH, MS William H. Herman, MD, MPH |
1:05 pm – 1:20 pm | Opening Remarks
Dorothy Fink, MD |
1:20 pm – 1:25 pm | Review of the agenda
William H. Herman, MD, MPH |
1:25 pm – 1:40 pm | Executive Summary
|
1:40 pm – 1:55 pm | Chapter 1: Background
|
1:55 pm – 2:10 pm | Chapter 2: Methods
|
2:10 pm – 2:25 pm | Chapter 3: Foundational Recommendations to Address Diabetes in the U.S.
|
2:25 pm – 2:40 pm | Chapter 4: Population-Level Diabetes Prevention and Control
|
2:40 pm – 3:00 pm | BREAK |
3:00 pm – 3:15 pm | Chapter 5: Diabetes Prevention in Populations at High-Risk
|
3:15 pm – 3:30 pm | Chapter 6: Diabetes Treatment and Complications
|
3:30 pm – 3:45 pm | Chapter 7: Looking Forward (?)
|
3:45 pm – 3:55 pm | Appendices
|
3:55 pm – 4:05 pm | Table of Contents
|
4:05 pm – 4:35 pm | Oral Public Comments |
4:35 pm – 5:15 pm | Meeting Review, Next Steps, Concluding Remarks and Acknowledgments
William H. Herman, MD, MPH All Commission Members |
5:15 pm – 5:20 pm | Closing Remarks
Dorothy Fink, MD |
5:20 pm | Adjournment
Kara Elam, PhD, MPH, MS |